Related Experiment Videos
Islet transplantation in IDDM patients
1Department of Internal Medicine, San Raffaele Scientific Institute, University of Milan, Italy.
Diabetologia
|February 1, 1997
Summary
Islet allotransplantation in insulin-dependent diabetic patients is safe, with a 45% success rate. Higher numbers of transplanted islets positively correlate with improved outcomes, potentially leading to insulin independence.
Area of Science:
- Endocrinology
- Transplantation Immunology
- Metabolic Diseases
Background:
- Insulin-dependent diabetes mellitus (IDDM) requires lifelong insulin therapy.
- Islet allotransplantation offers a potential alternative to exogenous insulin.
- Factors influencing islet transplantation success require further investigation.
Purpose of the Study:
- To identify parameters correlating with successful islet allotransplantation outcomes in IDDM patients.
- To evaluate the safety and efficacy of intrahepatic islet transplantation.
Main Methods:
- Retrospective analysis of 21 intrahepatic islet transplantations in 20 IDDM patients.
- Correlation analysis between transplanted islet quantity/purity and patient outcomes.
- Assessment of metabolic parameters including serum C-peptide and HbA1c levels.
Main Results:
- A 45% success rate was observed, defined by insulin independence or >50% reduction in insulin requirement.
- Successful islet transplantation positively correlated with the number of transplanted islets (p < 0.05).
- Early graft failure ('presumed rejection') occurred in 15% of patients; 40% showed no metabolic effect ('presumed function exhaustion').
Conclusions:
- Islet allotransplantation is a safe procedure for IDDM patients.
- The number of transplanted islets is a critical factor for successful outcomes.
- While promising, islet transplantation success can be transient, necessitating ongoing monitoring.